Skip to content

Lung ultrasound score to predict the need of second dose of surfactant and respiratory outcomes in neonatal respiratory distress syndrome

An early lung ultrasound score predicts the need for surfactant retreatment and long-term outcomes in neonatal respiratory distress syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN88324348
Enrollment
225
Registered
2025-09-19
Start date
2022-03-01
Completion date
Unknown
Last updated
2025-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal respiratory distress syndrome Neonatal Diseases

Interventions

Preterm neonates stabilized according to the local NICU protocol and managed with any kind of respiratory support are enrolled within 120 minutes of birth when important prenatal variables were record

Sponsors

University of Naples Federico II
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Premature neonates with respiratory distress syndrome (RDS) 2. Born between 25- 33 weeks of gestational age calculated from the first day of the last menstrual period 3. Studied before their first surfactant dose

Exclusion criteria

Exclusion criteria: 1. Lack of parental consent 2. Major congenital malformations 3. Surfactant administration before lung ultrasound

Design outcomes

Primary

MeasureTime frame
Early LUS performance as a predictor of the second surfactant dose administration by a masked attending physician. LUS is performed in the first 2 hours of life using the Brat score.

Secondary

MeasureTime frame
Main respiratory outcomes in relation to the need for a second surfactant dose, measured by evaluating oxygen indices and the respiratory technique used at stabilization. Bronchopulmonary dysplasia (according to the Jensen definition) and the number of deaths will be registered at discharge.

Countries

Italy

Contacts

Public ContactFrancesco Raimondi
raimondi@unina.it+ 39 (0)81 746 3004

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026